Avinger releases updated data from IMAGE-BTK study in webinar
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2024
0mins
Webinar Overview: Avinger hosted a webinar discussing new approaches to treating Peripheral Artery Disease (PAD) below-the-knee, featuring expert presentations from Dr. Michael Lichtenberg on treatment challenges and future perspectives, and Dr. Thomas Davis on the Pantheris SV device and interim data from the IMAGE-BTK study.
Study Findings: The IMAGE-BTK study demonstrated promising safety and efficacy results for the Pantheris SV device, with 100% freedom from major adverse events at 30 days and high rates of primary patency and freedom from target lesion revascularization at 12 months.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
